Acute insomnia: experience of treatment with doxylamine

Insomnia is a common clinical condition characterized by difficulty initiating and/or maintaining sleep. According to most epidemiological studies, about third of adults (30–36%) report at least one symptom insomnia, such as having falling asleep or interferes with the full-fledged social and professional functioning patients, forcing them visit doctors more often, take sick leave. While therapeutic approaches are actively developed discussed in chronic acute insomnia due transient state tendency (in some cases) spontaneous resolution often remains subject underdiagnosis undrtreatment. Antihistamines that non-addictive have narrower side-effect profile nonprescription drugs an alternative pharmacological treatment especially secondary which widespread population. Donormil (doxylamine succinate) blocker H1-histamine receptors from ethanolamine group. Doxylamine successfully used both psychiatric general medical practice, including dermatology, allergology, gynecology.This article presents observation patient arising adjustment disorder was accompanied anxiety mild conversion symptoms.. therapy during two weeks allowed reduce insomnia: time fall number night awakenings decreased, cognitive impairment, distraction, asthenia associated reduced. No significant side effects were observed.